Biological Drugs in Guillain-Barré Syndrome: An Update

BACKGROUND: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Neuropharmacol
Hlavní autoři: Motamed-Gorji, Nazgol, Matin, Nassim, Tabatabaie, Omidreza, Pavone, Piero, Romano, Catia, Falsaperla, Raffaele, Vitaliti, Giovanna
Médium: Artigo
Jazyk:Inglês
Vydáno: Bentham Science Publishers 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652014/
https://ncbi.nlm.nih.gov/pubmed/27964705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666161213114904
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky